Ginkgo Bioworks CFO sells shares to cover taxes

Ginkgo Bioworks Holdings, Inc. Chief Financial Officer Steven P. Coen reported RSU vesting and related share movements.

Accepted by SEC EDGAR 07/20/2026 - 05:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Ginkgo Bioworks Holdings, Inc. Chief Financial Officer Steven P. Coen reported RSU vesting and related share movements. On July 16, 2026, 1,486 restricted stock units converted into Class A Common Stock. On July 17, 2026, he sold 752 shares at $7.903 per share to cover tax withholding obligations through a non-discretionary sell-to-cover arrangement.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Coen Steven P.

Role See remarks

Sold 752 shs ($6K)

Approx. gross sale proceeds $6K

Share of Position Sold 1.4%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F2	752	$7.903	$6K
Exercise	Restricted Stock Units F1, F3	1,174	--	--
Exercise	Restricted Stock Units F1, F4	312	--	--
Exercise	Class A Common Stock F1	1,174	--	--
Exercise	Class A Common Stock F1	312	--	--

Holdings After Transaction: Restricted Stock Units — 9,014 contracts (Direct); Class A Common Stock — 51,438 shares (Direct)

Holdings Before and After: Restricted Stock Units, 10,500 to 9,014 contracts (Direct); Class A Common Stock, 50,704 to 51,438 shares (Direct)

Footnotes (4)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. F2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
3. F3. The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
4. F4. The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Key Figures

Shares sold: 752 shares Sale price: $7.903 per share RSUs converted: 1486 shares +2 more

5 metrics

Shares sold 752 shares Class A Common Stock sold on July 17, 2026 to cover taxes

Sale price $7.903 per share Price for 752-share tax sell-to-cover transaction on July 17, 2026

RSUs converted 1486 shares Total restricted stock units converting into Class A Common Stock on July 16, 2026

RSU installments (F3) 36 monthly installments Remaining vesting after initial 25% RSU vesting on May 1, 2024

RSU installments (F4) 46 monthly installments Remaining vesting after initial 2/48ths RSU vesting on May 1, 2024

Key Terms

Restricted Stock Units, sell to cover, tax withholding obligations, equity incentive plans

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

tax withholding obligations financial

"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting"

equity incentive plans financial

"The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded"

Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Ginkgo Bioworks (DNA) CFO Steven P. Coen report in July 2026?

CFO Steven P. Coen reported 1,486 RSUs converting into Class A Common Stock on July 16, 2026, and a sale of 752 shares on July 17, 2026. The sale was executed solely to satisfy tax withholding obligations tied to equity vesting.

How many Ginkgo Bioworks (DNA) shares did the CFO sell and at what price?

Steven P. Coen sold 752 shares of Ginkgo Bioworks Class A Common Stock at $7.903 per share. According to the disclosure, these shares were sold under a sell-to-cover arrangement to fund tax withholding obligations arising from vested restricted stock and restricted stock units.

Were the Ginkgo Bioworks (DNA) insider share sales by the CFO discretionary trades?

The reported sale of 752 shares is described as a non-discretionary transaction to cover tax withholding obligations tied to vesting. The company’s equity incentive plans permit satisfying these obligations through a “sell to cover” transaction, meaning the trade was not an elective open-market sale.

What RSU vesting schedules apply to the Ginkgo Bioworks (DNA) awards referenced in this Form 4?

One RSU grant vests with 25% of shares on May 1, 2024, followed by 36 equal monthly installments. Another vests with 2/48ths of shares on May 1, 2024, then 46 equal monthly installments, defining the ongoing release of shares to the CFO.

Were Ginkgo Bioworks (DNA) CFO transactions reported under a Rule 10b5-1 trading plan?

The disclosure does not indicate that these trades were made under a Rule 10b5-1 trading plan. Instead, the footnotes state the sale was executed to cover tax withholding obligations in connection with equity vesting under the company’s equity incentive plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coen Steven P.

(Last) (First) (Middle)

C/O GINKGO BIOWORKS HOLDINGS, INC.

27 DRYDOCK AVENUE

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/16/2026		M(1)		1,174	A	(1)	51,878	D
Class A Common Stock	07/16/2026		M(1)		312	A	(1)	52,190	D
Class A Common Stock	07/17/2026		S(2)		752	D	$7.903	51,438	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/16/2026		M(1)			1,174	(3)	(3)	Class A Common Stock	1,174	(1)	5,883	D
Restricted Stock Units	(1)	07/16/2026		M(1)			312	(4)	(4)	Class A Common Stock	312	(1)	3,131	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.

3. The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.

4. The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Remarks:

Chief Financial Officer

	/s/ Karen Tepichin, Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)